Funded Tech Companies

Epicrispr Biotechnologies

Headquartered in San Francisco, Epicrispr Biotechnologies has funding from Ally Bridge Group, Solve FSHD and private investors.

Company Overview

Company Name
Epicrispr Biotechnologies
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
7000 Shoreline Court 100
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Not Recorded

Company Background Information

Overview
Epicrispr Biotechnologies is building the world's leading therapeutic platform based on the exciting new technology of epigenetic editing. We were founded by genetic medicine pioneer Stanley Qi, Ph.D., whose fundamental work in epigenetic editing includes the invention of CRISPRa (activation) and CRISPRi (interference). We are translating the powerful potential of epigenetic editing into transformative therapies that can expand the promise of genetic medicine and improve the lives of people with serious diseases.
Profile
Epicrispr Biotechnologies LinkedIn Company Profile
Social Media
Epicrispr Biotechnologies Company Twitter Account
Company News
Epicrispr Biotechnologies News
Facebook
Epicrispr Biotechnologies on Facebook
YouTube
Epicrispr Biotechnologies on YouTube
Last Transaction
3/26/2025

Financing History

Date
Type
Amount
Venture Equity
$68,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Amber Salzman
  Amber Salzman LinkedIn Profile  Amber Salzman Twitter Account  Amber Salzman News  Amber Salzman on Facebook


Company Investors

  • Ally Bridge Group (Andrew Lam)
  • Solve FSHD (Chip Wilson)

 

 

 

Browse more funded tech companies:

EpicPledge | Epicrop Technologies

 

Share this article

 


About Our VC Deals Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary